Responses
Regular Abstracts – Part 2
Clinical Trial Completed
629-A A safety and feasibility study of the oral live biotherapeutic MRx0518 with hypofractionated preoperative radiation for resectable pancreatic cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
